Clinical Trials Browser

Withdrawn × OTHER × Cryotherapy × Clear all

NCT01735942 2021-12-06

Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions

Phase EARLY_PHASE1 Withdrawn

Keratosis, Actinic

NCT03484962 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Phase 2 Withdrawn

Gastrointestinal

Liver Neoplasms

NCT03501056 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Phase 2 Withdrawn

Lung Neoplasms

NCT03509298 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT03524261 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT03524274 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03540199 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Phase 2 Withdrawn

Kidney Neoplasms

NCT03554395 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer

Phase 2 Withdrawn

Gastrointestinal

Stomach Neoplasms

NCT03523299 2019-08-21

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

Phase NA Withdrawn

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00814528 2018-09-10

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Phase NA Withdrawn

Keratosis, Actinic

NCT01325753 2018-07-03

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Phase NA Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT02961816 2017-04-21

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

Phase 2 Withdrawn

Hodgkin Disease, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse